Corporate Action6 Oct 2026, 06:50 pm
Shukra Pharmaceuticals Allots 17.35 Lakh Shares on Warrant Conversion
AI Summary
Shukra Pharmaceuticals Ltd announced the allotment of 17,35,000 fully paid-up equity shares following the conversion of warrants. The allotment was made on a preferential basis to Ms. Anar Jayesh Patel and Anar Projects Private Limited, who are promoters. The conversion involved the exercise of warrants at a price of Rs. 26.67 per share, aggregating to Rs. 4,62,72,450. This issuance increases the company's paid-up equity capital to Rs. 44,25,22,440. Following this allotment, there are no outstanding warrants for conversion.
Key Highlights
- 17,35,000 equity shares allotted upon warrant conversion.
- Allotment made on preferential basis to promoters.
- Total funds raised from conversion: Rs. 4,62,72,450.
- Paid-up equity capital increased post-allotment.
- No outstanding warrants remain for conversion.
Price Impact
More from SHUKRAPHAR